New research by the National Institutes of Health’s National Institute of Mental Health published online by The American Journal of Psychiatry shows that schizophrenic children treated with newer antipsychotic Zyprexa from Eli Lilly and Risperdal from Janssen appear to have no better health outcomes compared to those treated with older, less
read more | digg story
No comments:
Post a Comment